Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 Workshop
- 31 July 1996
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 32 (8) , 1371-1381
- https://doi.org/10.1016/0959-8049(96)00118-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Relationship of PS2 with response to tamoxifen therapy in patients with recurrent breast cancerBritish Journal of Cancer, 1994
- Biology and biochemistry of proteinases in tumor invasionPhysiological Reviews, 1993
- Urokinase-type plasminogen activator (u-PA) antigen is a predictor of early relapse in breast cancerFibrinolysis, 1990
- Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary reportCancer, 1988
- Plasminogen Activators, Tissue Degradation, and CancerPublished by Elsevier ,1985
- Standardization of Steroid Receptor Analysis in Breast Cancer Biopsies: EORTC Receptor GroupPublished by Springer Nature ,1984
- Historical perspectiveCancer, 1980
- Quantitative estrogen receptor analyses: The response to endocrine and cytotoxic chemotherapy in human breast cancer and the disease-free intervalCancer, 1980
- RELATIONSHIP OF ŒSTROGEN-RECEPTOR STATUS TO SURVIVAL IN BREAST CANCERThe Lancet, 1979
- Patterns of relapse and survival following radical mastectomy.Analysis of 716 consecutive patientsCancer, 1978